2026-09-24T14:46:17-05:00 2025-12-31 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 800N BETHESDA MD 208142930 990 2025-01-01 450672514 USAGAINSTALZHEIMER'S USAG 2024105199 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 MICHAEL CLEARY CFO 2024105199 2026-09-24 1 ELIZABETH W HELLER P00397829 3019519090 2025 MICHAEL CLEARY 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 20250072 0 X WWW.USAGAINSTALZHEIMERS.ORG X 2011 DC SEE PART III, LINE 1. 9 8 23 20 0 0 9647520 19190621 438350 65000 374064 331066 10239 1440 10470173 19588127 205825 170819 0 0 3250124 3558676 0 0 1201573 5933514 12553390 9389463 16282885 1080710 3305242 10098847 13757675 323413 676999 9775434 13080676 X USAGAINSTALZHEIMER'S IS ENGAGED IN A RELENTLESS PURSUIT TO END ALZHEIMER'S, THE SIXTH LEADING KILLER IN AMERICA. OUR WORK CENTERS ON PREVENTION, RISK REDUCTION, EARLY DETECTION AND DIAGNOSIS, AND ACCESS TO TREATMENTS ALL REGARDLESS OF GENDER, RACE, (CONTINUED ON SCH O) OR ETHNICITY. BECAUSE ALZHEIMER'S DISPROPORTIONATELY AFFECTS WOMEN, BLACK COMMUNITIES, AND LATINO COMMUNITIES, EQUITY IS EMBEDDED THROUGHOUT OUR WORK TO ENSURE THAT THOSE MOST IMPACTED BY THE DISEASE HAVE ACCESS TO THE INFORMATION, CARE, RESOURCES, AND OPPORTUNITIES THEY NEED. TO ACHIEVE OUR MISSION, WE ELEVATE THE VOICES OF PATIENTS AND CAREGIVERS WHILE BRINGING TOGETHER LEADERS FROM GOVERNMENT, SCIENCE, HEALTHCARE, THE PRIVATE SECTOR, AND ALLIED ORGANIZATIONS-THE PEOPLE WHO PUT THE "US" IN USAGAINSTALZHEIMER'S. 0 0 14164295 170819 65000 USAGAINSTALZHEIMER'S HAS WORKED ACROSS SECTORS TO ACHIEVE IMPORTANT MILESTONES, INCLUDING:-ADVANCING MORE REPRESENTATIVE CLINICAL TRIALS BY CONVENING A MULTI-SECTOR COMMITTEE OF EXPERTS TO IMPROVE THE GENERALIZABILITY OF ALZHEIMER'S DISEASE CLINICAL TRIALS. LAUNCHED IN NOVEMBER 2025, THE INITIATIVE DEVELOPED PARTICIPANT ENROLLMENT GOALS AND GUIDANCE TO HELP ENSURE CLINICAL TRIAL POPULATIONS BETTER REFLECT THOSE MOST AFFECTED BY ALZHEIMER'S DISEASE.-EXPANDING ACCESS TO BRAIN HEALTH RESOURCES VIA BRAINGUIDE, A FREE ONLINE BRAIN HEALTH PLATFORM, WHICH SURPASSED ONE MILLION VISITORS NATIONWIDE IN 2025. (CONTINUED ON SCHEDULE O) APPROXIMATELY 500,000 INDIVIDUALS COMPLETED THE PLATFORM'S MEMORY QUESTIONNAIRE, TAKING AN IMPORTANT FIRST STEP TOWARD UNDERSTANDING THEIR COGNITIVE HEALTH AND SEEKING APPROPRIATE FOLLOW-UP CARE.-PROMOTING BRAIN HEALTH EQUITY THROUGH ITS CENTER FOR BRAIN HEALTH EQUITY, WHICH EXPANDED ACCESS TO TRUSTED BRAIN HEALTH INFORMATION FOR COMMUNITIES DISPROPORTIONATELY IMPACTED BY ALZHEIMER'S DISEASE, REACHING MORE THAN THREE MILLION BLACK AND LATINO INDIVIDUALS THROUGH CULTURALLY TAILORED OUTREACH AND EDUCATION EFFORTS.-DRIVING CHANGE BY HELPING TO ADVANCE THE BIPARTISAN REINTRODUCTION OF THE CONCENTRATING ON HIGH-VALUE ALZHEIMER'S NEEDS TO GET TO AN END ACT (CHANGE) ACT, LEGISLATION DESIGNED TO IMPROVE EARLY DETECTION AND ALZHEIMER'S CARE. THE ORGANIZATION ALSO CONTINUED ADVOCATING FOR ROBUST FEDERAL INVESTMENT IN ALZHEIMER'S RESEARCH AND PUBLIC HEALTH PROGRAMS, SUPPORTING POLICIES THAT ACCELERATE SCIENTIFIC PROGRESS AND IMPROVE OUTCOMES FOR PATIENTS AND FAMILIES.-MOBILIZING THE BUSINESS COMMUNITY THROUGH THE BUSINESS COLLABORATIVE FOR BRAIN HEALTH (BCBH), WHICH CONVENED MORE THAN 200 LEADERS FROM BUSINESS, RESEARCH, HEALTHCARE, AND INNOVATION SECTORS AT THE HOUSTON ROUNDTABLES IN 2025. THESE DISCUSSIONS GENERATED NEW CROSS-SECTOR STRATEGIES TO ADVANCE BRAIN HEALTH AND HELPED LAUNCH 'PROJECT METIS', AN INITIATIVE AIMED AT ESTABLISHING HOUSTON AS A GLOBAL LEADER IN BRAIN HEALTH INNOVATION. 14164295 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 1 78 0 1 23 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AR CA FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X X MICHAEL CLEARY 2024105199 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 X MERYL COMER BOARD MEMBER (SEE SCH O) 40.00 X 200000 0 0 GEORGE VRADENBURG CHAIRMAN 10.00 X X 0 0 0 SHAWN TAYLOR TREASURER 1.00 X X 0 0 0 KAREN SEGAL SECRETARY 2.00 X X 0 0 0 JOHN DWYER BOARD MEMBER 1.00 X 0 0 0 GREG O'BRIEN BOARD MEMBER 1.00 X 0 0 0 PAUL HOGAN BOARD MEMBER 1.00 X 0 0 0 REBECCA CHOPP PHD BOARD MEMBER (9/25) 1.00 X 0 0 0 KARIN HELLSVIK BOARD MEMBER 1.00 X 0 0 0 RUSSELL PAULSEN CHIEF OPERATING OFFICER 50.00 X 352939 0 25577 LYNN M CRONEBERGER CHIEF DEVELOPMENT OFFICER 50.00 X 213069 0 27936 MICHAEL JOHN CLEARY CHIEF FINANCIAL OFFICER 46.00 X 209254 0 27412 VIVIAN S VASALLO VICE PRESIDENT, EARLY DETECTION 50.00 X 184427 0 25669 KELLY M O'BRIEN V.PRESIDENT, PREVENTION (END 11/25) 50.00 X 167890 0 18653 M'LISS L REINGRUBER DIRECTOR OF FINANCE AND OPERATIONS 48.00 X 160020 0 11525 1487599 0 136772 15 0 1 0 PURPLE STRATEGIES LLC 815 SLATERS LANE ALEXANDRIA VA 22314 COMMUNICATIONS/PAID MEDIA 4531994 HIGH LANTERN GROUP 685 THIRD AVE 22ND FLOOR NEW YORK NY 10017 PROGRAM STRATEGY/MGMT 2091909 RTI HEALTH SOLUTIONS 3040 EAST CORNWALLIS ROAD RESARCH TRIANGLE NC 27709 PROGRAM STRATEGY/MGMT 785114 GLOBAL STRATEGY GROUP LLC 215 PARK AVENUE SOUTH 15TH FLOOR NEW YORK NY 10003 COMMUNICATIONS/MEDIA 432373 IAN N KREMER 2920 PARKLAWN CT HERNDON VA 20171 PROGRAM STRATEGY/MGMT 398304 15 457872 312943 18419806 610892 19190621 PROGRAM SERVICE REVENUE 900099 65000 65000 65000 330939 330939 608769 608642 127 127 127 24000 457872 53303 -29303 -29303 OTHER REVENUE 900099 30743 30743 30743 19588127 65000 0 332506 X 102500 102500 26000 26000 42319 42319 507671 402404 29320 75947 2496990 1379094 393650 724246 165397 87235 30176 47986 169337 93583 28188 47566 219281 121184 36502 61595 136508 136508 108244 26000 56244 26000 5771910 5658769 86821 26320 4409956 4409956 109784 56903 36710 16171 508445 435396 18829 54220 410857 296632 34232 79993 990297 981758 3028 5511 13562 13562 PAYROLL FEES 77111 42615 12836 21660 STATE REGISTRATION FEES 13818 13818 MISCELLANEOUS 2898 1947 411 540 16282885 14164295 917017 1201573 257240 508825 9425830 12379890 323736 730033 92041 105081 33846 10098847 13757675 323413 469999 207000 323413 676999 X 3348971 4678011 6426463 8402665 9775434 13080676 10098847 13757675 3305242 0 X 0 1 X 1 0 X 10826065 8346783 7907949 9647520 19190621 55918938 10826065 8346783 7907949 9647520 19190621 55918938 19971069 35947869 557 23745 325816 373185 330939 1054242 4980 20281 21601 30743 77605 57050785 4220723 0.63010 0.61960 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 19588127 0 19588127 0 19588127 16282885 0 16282885 0 16282885 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES CONVENING IN LAUSANNE, SWITZERLAND WITH CROSS SECTOR ALZHEIMER'S STAKEHOLDERS FROM AROUND THE WORLD 245339 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANT TO RECIPIENT LOCATED IN REGION 42319 NORTH AMERICA 0 0 PROGRAM SERVICES ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE IN TORONTO, CANADA 85996 0 0 0 0 0 0 373654 0 373654 EUROPE SPONSORSHIP FOR AD/PD CONFERENCE IN COPENHAGEN 42319 WIRE TRANSFER 0 1 0 1 0 0 0 0 0 PART I, LINE 2: EVENT SPONSORSHIPS WERE NOT MONITORED AFTER AWARD. USA2 HAD REPRESENTATIVES ATTEND THE EVENTS. NOGALAGALA 115856 114666 1190 8967 1250 FALL FEST 269500 259540 9960 4267 9773 2702 1 96516 83666 12850 25000 1344 481872 457872 24000 25000 4267 18740 5296 53303 -29303 1 ALLIANCE FOR AGING RESEARCH 1700 K STREET NW WASHINGTON DC 20006 541379174 501(C)(3) 10000 0 EVENT SPONSORSHIP ALZHEIMER'S DRUG DISCOVERY FOUNDATION 57 WEST 57TH STREET SUITE 904 NY NY 10019 201082179 501(C)(3) 10000 0 EVENT SPONSORSHIP AMERICAN ACADEMY OF NEUROLOGY 201 CHICAGO AVENUE MINNEAPOLIS MN 55415 611532062 501(C)(3) 25000 0 EVENT SPONSORSHIP BRIGHTFOCUS FOUNDATION 22512 GATEWAY CENTER DR CLARKSBURG MD 20871 277337229 501(C)(3) 10000 0 EVENT SPONSORSHIP CARINGKIND 360 LEXINGTON AVE FL NEW YORK NY 10017 133277408 501(C)(3) 25000 0 EVENT SPONSORSHIP EXPOSE DEMENTIA PO BOX 1751 MABLETON GA 30126 992928801 501(C)(3) 10000 0 EVENT SPONSORSHIP LUMIND IDSC FOUNDATION 1155 15TH ST NW STE 540 WASHINGTON DC 20005 371483975 501(C)(3) 10000 0 EVENT SPONSORSHIP 7 0 NURSE FELLOWSHIP GRANTS 14 26000 PART I, LINE 2: EVENT SPONSORSHIPS WERE NOT MONITORED AFTER AWARD. SOMETIMES USA2 HAD REPRESENTATIVES ATTEND THE EVENTS. GENERAL SUPPORT GRANTS ARE MONITORED VIA PROGRESS REPORTS AND IN-PERSON MEETINGS TO DISCUSS RESEARCH FINDINGS. BRAIN HEALTH NURSE FELLOWS WERE REQUIRED TO COMPLETE LEADERSHIP TRAINING PROVIDEDBY USA2 AND PARTICIPATE IN COMMUNITY EVENTS. X X X X 0 0 0 0 0 0 0 1 0 RUSSELL PAULSEN CHIEF OPERATING OFFICER 319229 0 33710 0 0 0 24500 0 1077 0 378516 0 0 0 LYNN M CRONEBERGER CHIEF DEVELOPMENT OFFICER 213069 0 0 0 0 0 15161 0 12775 0 241005 0 0 0 MICHAEL JOHN CLEARY CHIEF FINANCIAL OFFICER 209254 0 0 0 0 0 14630 0 12782 0 236666 0 0 0 VIVIAN S VASALLO VICE PRESIDENT, EARLY DETECTION 184427 0 0 0 0 0 12950 0 12719 0 210096 0 0 0 MERYL COMER BOARD MEMBER (SEE SCH O) 200000 0 0 0 0 0 0 0 0 0 200000 0 0 0 KELLY M O'BRIEN V.PRESIDENT, PREVENTION (END 11/25) 163454 0 0 0 4436 0 8487 0 10166 0 186543 0 0 0 M'LISS L REINGRUBER DIRECTOR OF FINANCE AND OPERATIONS 160020 0 0 0 0 0 10618 0 907 0 171545 0 0 0 PART I, LINE 7 RUSSELL PAULSEN, COO, RECEIVED A MERIT-BASED BONUS PAYMENT OF $33,710 DURING 2025. X 4 2250 FMV X 5 608642 FMV 0 0 0 0 PART I, COLUMN (B): THIS COLUMN REPORTS THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED BY ONE OF THE DIRECTORS AND THE CHIEF FINANCIAL OFFICER. A COPY OF THE FORM 990 WAS PROVIDED TO THE ORGANIZATION'S GOVERNING BODY BEFORE IT WAS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS ANNUALLY SIGNS A STATEMENT WHICH AFFIRMS THAT EACH HE/SHE: A. HAS RECEIVED A COPY OF THE CONFLICTS OF INTEREST POLICY, B. HAS READ AND UNDERSTANDS THE POLICY, C. HAS AGREED TO COMPLY WITH THE POLICY, AND D. UNDERSTANDS THAT THE ORGANIZATION IS A NON-PROFIT PUBLIC BENEFIT CORPORATION AND, IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION, IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE LEAVES THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS DECIDE IF A CONFLICT OF INTEREST EXISTS. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION IS DISCUSSED WITH THE BOARD CHAIRMAN, WHO USES INFORMATION FROM A REVIEW OF COO COMPENSATION AT OTHER NON-PROFITS, AND A PERFORMANCE REVIEW IS CONDUCTED. THE COMPENSATION IS THEN APPROVED BY THE BOARD WHEN IT APPROVES THE BUDGET. THE MOST RECENT FORMAL SALARY COMPARISON TO OTHER NONPROFITS TOOK PLACE IN DECEMBER 2024. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART VII, LINE 1: USAGAINSTALZHEIMER'S (USA2) AND USAGAINSTALZHEIMER'S ACTION (USA2ACTION), AN UNRELATED ORGANIZATION FOR TAX PURPOSES, HAVE ENTERED INTO A COST-SHARING ARRANGEMENT UNDER WHICH USA2ACTION REIMBURSES USA2 FOR USA2ACTION'S ALLOCABLE SHARE OF THE COMPENSATION OF CERTAIN EMPLOYEES FOR SERVICES PROVIDED TO USA2ACTION. PURSUANT TO THIS AGREEMENT, USA2ACTION REIMBURSED USA2 FOR ITS SHARE OF OFFICER COMPENSATION AS FOLLOWS: RUSSELL PAULSEN: $70,125 FORM 990, PART VII, LINE 1: MERYL COMER RECEIVED COMPENSATION FOR HER WORK AS A SENIOR PROJECT ADVISOR. HER COMPENSATION IS UNRELATED TO HER DUTIES AS A BOARD MEMBER. FORM 990, PART IX, LINE 11G COMMUNICATIONS: PROGRAM SERVICE EXPENSES 1,161,671. MANAGEMENT AND GENERAL EXPENSES 39,947. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,201,618. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 513,170. MANAGEMENT AND GENERAL EXPENSES 46,874. FUNDRAISING EXPENSES 26,320. TOTAL EXPENSES 586,364. PROGRAM MGT STRATEGY: PROGRAM SERVICE EXPENSES 1,293,057. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,293,057. PROJECT FUNDS: PROGRAM SERVICE EXPENSES 2,690,871. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,690,871. FORM 990, PART IX, LINE 11G: FOR MANY SERVICES, USA2 CONTRACTS WITH FIRMS TO PROVIDE CORE CAPACITIES, INCLUDING POLICY/LEGISLATIVE AFFAIRS, COMMUNICATIONS AND MEDIA, DIGITAL MARKETING, AND PROGRAM MANAGEMENT. ALZHEIMERS DISEASE EVIDENCE ACCELERATOR INC 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 932101228 CREATE A PATIENT-FOCUSED LEARNING SYSTEM LEVERAGING REAL-WORLD HEALTH DATA DC 501(C)(3) LINE 7 USAGAINSTALZHEIMER'S 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0